-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, N3HWe8YWc31y87DX84go27FKojCDalTEKZQsjffCjxyVGLI2Dd+f3xq4sH2wKTo5 xCnEK/YUIv+j1RMntOax0w== 0001324517-07-000067.txt : 20070718 0001324517-07-000067.hdr.sgml : 20070718 20070718190113 ACCESSION NUMBER: 0001324517-07-000067 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070716 FILED AS OF DATE: 20070718 DATE AS OF CHANGE: 20070718 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 CHIPETA WAY STE 240 CITY: SALT LAKE CITY STATE: UT ZIP: 84108-1256 BUSINESS PHONE: 8015834939 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STILLER CALVIN CENTRAL INDEX KEY: 0001263259 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 07987510 BUSINESS ADDRESS: STREET 1: 148 FULLARTON STREET STREET 2: #2006 CITY: LONDON ONT STATE: A6 ZIP: N6A 5P3 BUSINESS PHONE: 4162134694 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2007-07-16 0000890465 NPS PHARMACEUTICALS INC NPSP 0001263259 STILLER CALVIN 383 COLOROW DRIVE SALT LAKE CITY UT 84108 1 0 0 0 Deferred Stock Units 2007-07-16 4 A 0 4553 0 A Common Stock 4553 36555 D Each Deferred Stock Unit represents a right to receive one share of NPS Common Stock. Deferred Stock Units awarded under the Nonemployee Directors' Deferred Compensation Program will be settled in NPS Common Stock upon (1) separation from service on the Board, (2) death, (3) disability, or (4) sale of substantially all the assets of the Company. Val R. Antczak 2007-07-18 -----END PRIVACY-ENHANCED MESSAGE-----